CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
The Food and Drug Administration last week approved a new formulation of the protease inhibitor Invirase made by Roche. The new 500-milligram tablets will decrease the pill burden for HIV patients from 10 pills to four pills daily. The tablets also are smaller in size than the 200-milligram capsules currently available. "With the new Invirase 500-milligram tablet now available, pill burden is considerably reduced, and we anticipate that this improved convenience, together with 'boosted' Invirase's record of convincing data, will result in an expansion of its use in the earlier stages of HIV therapy," said William Burns, head of Roche's pharmaceutical division, in a press statement.
From our Sponsors
Most Popular
Watch Now: Pride Today
Latest Stories
5 lesbian power couples who play for the same sports team
July 10 2025 12:13 PM
'Gay progressive hot daddy' blasts 'bozos' using his pics for right-wing memes
July 10 2025 11:59 AM